The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Amikacin 250 mg/ml Solution for injection/infusion



Noridem Enterprises LimitedPA1122/034/002

Main Information

Trade NameAmikacin 250 mg/ml Solution for injection/infusion
Active SubstancesAMIKACIN SULFATE
Dosage FormSolution for injection/infusion
Licence HolderNoridem Enterprises Limited
Licence NumberPA1122/034/002

Group Information

ATC CodeJ01GB06 amikacin

Status

License statusAuthorised
Licence Issued24/05/2024
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back